Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 18, Number 2—February 2012


Dengue Surveillance among French Military in Africa

Cite This Article


Highlight and copy the desired format.

EID de Laval F, Plumet S, Simon F, Deparis X, Leparc-Goffart I. Dengue Surveillance among French Military in Africa. Emerg Infect Dis. 2012;18(2):342-343.
AMA de Laval F, Plumet S, Simon F, et al. Dengue Surveillance among French Military in Africa. Emerging Infectious Diseases. 2012;18(2):342-343. doi:10.3201/eid1802.111333.
APA de Laval, F., Plumet, S., Simon, F., Deparis, X., & Leparc-Goffart, I. (2012). Dengue Surveillance among French Military in Africa. Emerging Infectious Diseases, 18(2), 342-343.

To the Editor: In their recent article, Amarasinghe et al. (1) describe dengue virus distribution in Africa. Their data were based on published reports of dengue cases among local populations and travelers returning from Africa. To complement the description by Amarasinghe and colleagues of dengue serotypes found in Africa, we report results from dengue virologic testing during 1998–2010. The tests were performed at the Arbovirus National Reference Center (Tropical Medicine Institute of the Military Health Service, Marseille, France).

Each year, ≈14,000 French soldiers are stationed in dengue-endemic areas of Africa (mainly Cameroon, Central African Republic, Chad, Djibouti, Gabon, Côte d’Ivoire, Senegal, and Mayotte and Reunion islands), from which they travel throughout Africa. The population of soldiers is under constant epidemiologic surveillance. If symptoms of dengue fever develop in a soldier, a blood sample and a dengue-specific questionnaire from the patient are sent to the Tropical Medicine Institute of the Military Health Service. Virus culture and reverse transcription PCR, or both, were performed on early samples; otherwise, serologic testing was performed by using in-house assays (IgM antibody capture ELISA and direct IgG ELISA).

During the 12 years of surveillance, the laboratory received 2,423 samples from patients with suspected dengue within the French Armed Forces in Africa. Of these, 224 were probable acute dengue infections: 202 had positive IgM serologic results for dengue, and 22 were confirmed as dengue cases by RT-PCR or culture (Table). Serologic data may be confusing because of potential cross-reactions with other flavivirus antibodies (in particular in Chad with West Nile virus).

Because of probable underreporting from the field, our reported number of confirmed dengue cases likely underestimates the actual number of cases among French troops stationed in Africa. Nonetheless, our data complement those reported by Amarasinghe et al. by demonstrating additional locations for circulation of serotype 1 (Cameroon, Djibouti, Gabon, Mayotte) and serotype 3 (Comoros). Military epidemiologic surveillance systems can detect dengue circulation where soldiers stay. Thus, these systems could serve to evaluate the risk for dengue infection in countries without local epidemiologic surveillance systems, thereby improving knowledge about dengue circulation in African countries.

Franck de Laval, Sébastien Plumet, Fabrice Simon, Xavier Deparis, and Isabelle Leparc-GoffartComments to Author 

Author affiliations: Epidemiologic and Public Health Military Center, Marseille, France (F. de Laval, X. Deparis); French Army Forces Biomedical Institute, Marseille (S. Plumet, I. Leparc-Goffart); Laveran Military Hospital, Marseille (F. Simon)


  1. Amarasinghe A, Kuritsky JN, Letson GW, Margolis HS. Dengue virus infection in Africa. Emerg Infect Dis. 2011;17:134954.PubMed


Cite This Article

DOI: 10.3201/eid1802.111333

Related Links

Table of Contents – Volume 18, Number 2—February 2012


Please use the form below to submit correspondence to the authors or contact them at the following address:

Isabelle Leparc-Goffart, IRBA Marseille, Parc du Pharo, BP60109, 13262 Marseille Cedex 07, France

character(s) remaining.

Comment submitted successfully, thank you for your feedback.